Artículos Comentados

Unprotected Left Main Stenting in the Real World. Two-Year Outcomes of the French Left Main Taxus Registry. - AIRTON ARRUDA

COMENTARIO EDITORIAL: A population-based study of the drug interaction between proton pump inhibitors and lopidogrel - Jorge Augusto N. Guimarães

Analysis of Left Main Coronary Artery Bifurcation Lesions Treated With Biolimus-Eluting DEVAX AXXESS Plus Nitinol Self-Expanding Stent: Intravascular Ultrasound Results of the AXXENT Trial - Leandro Lasave, MD

3-Year Follow-Up of the SISR (Sirolimus-Eluting Stens Versus Vacular Brachytherapy for In-Stent Restenosis) Trial. - JUAN SIMÓN MUÑOZ, MD, FACC

Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations
The CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study - Circulation. 2009;119:71-78 - Dr. J. Airton Arruda MD, PhD, FSCAI

Efectividad y Seguridad de los Stents Farmacológicos en Ontario - Comentarios de Drs. José de Ribamar Costa Jr. y Dr. Alexandre Abizaid.

Percutaneous Intervention on the Saphenous Vein Bypass Grafts—Long-Term Outcomes - Dr. Juan Simón Muñoz, MD, FACC

Cambio valvular aórtico percutáneo - un análisis crítico - Dra. Deborah Nercolini, MD

Immediate and Long-Term Outcomes of Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease: Comparison With Bare-Metal Stent Implantation - Dr. Juan Simón Muñoz, MD, FACC

Paclitaxel-Eluntig Coronary Stents in Patients With Diabetes Mellitus: Pooled Analysis From 5 Randomized Trials - Dr. Juan Simón Muñoz, MD, FACC

Estrategia invasiva precoz guiada por la isquemia después de terapia fibrinolítica en el infarto agudo del miocardio. Metanálisis de estudios randomizados contemporaneos - Dr. Leandro I. Lasave, MD

Long-Term Impact of Drug-Eluting Stents Versus Bare-Metal Stents on All-Cause Mortality - Dr. J. Airton Arruda MD, PhD, FSCAI

Penetración de DES 2007 en Latinoamérica: 29.6% Una Realidad Multifactorial - Dr. Darío Echeverri, MD

La "saga" COURAGE llega a su último estudio - Drs. J. Airton Arruda, Jorge Guimarães, Juan Muñoz y Leandro Lasave.

Optimal treatment of carotid artery disease. State-of-the-art paper - Dr. Juan Simón Muñoz, MD, FACC

PercutAneous INTervention with biodegradable-polymer based paclitaxel-eluting, sirolimus-eluting, or bare stents for the treatment of new coronary lesions (PAINT) - Dr. J. Airton Arruda MD, PhD, FSCAI

Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody coated stent: A prospective single-center registry in high-risk patients - Dr. J. Airton Arruda MD, PhD, FSCAI

Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: Intravascular ultrasound results from ENDEAVOR III - Dr. Jorge Augusto Guimarães, MD

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention:

Long-Term Outcomes with Drug-eluting Stents versus Bare-Metal Stents in Sweden: Registro SCAAR – Una herida superficial, pero con una cicatriz profunda... - Drs. José de Ribamar Costa Jr., Dimytri Siqueira, Rodolfo Staico, Ricardo A. Costa

Comentario Editorial: Dr. Hugo F. Londero MD, FSCAI

Efectividad y Seguridad de los Stents Farmacológicos en Ontario - Los resultados a dos años de una muestra poblacional, “propensity-matched cohort study” sugieren que los DES son más efectivos que los BMS - Dr. Leandro I. Lasave, MD

Los dispositivos de extracción de trombo coronario en el IAM - Dr. Jorge Augusto Guimarães, MD

Angina intra esfuerzo como criterio de positividad: ¿un oráculo más de la ergometria ? - Dr. Augusto Uchida, MD

“La estrategia invasiva precoz es segura y más efectiva en la reducción de la isquemia refractaria en los pacientes con síndromes coronarios agudos sin elevación del ST” - J. AIRTON ARRUDA, MD, PhD, FSCAI

Comparación de los Stents Metálicos versus los Stents Liberadores de Medicamentos para las indicaciones “off-label” - Dr. Leandro Lasave, MD.

Outcomes with Drug-eluting stents versus Bare metal stents in Acute Myocardial Infarction. Results From the Strategic Transcatheter Evaluation of New Therapies (STENT) Group - Dr. Leandro Lasave, MD